cassiopeia: update on daratumumab maintenance for multiple myeloma
Published 3 years ago • 483 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
3:55
cassiopeia: analysis of daratumumab maintenance for myeloma
-
5:09
myeloma: maia, columba, and cassiopeia updates
-
4:48
daratumumab maintenance after treatment with vtd w/dara and asct in pts with ndmm: cassiopeia part 2
-
1:25
an update on the emn19 study: dara-vcd in multiple myeloma
-
2:39
the cassiopeia trial - assessing daratumumab in the context of stem cell transplantation
-
1:35
the value of ctcs and cfdna as novel biomarkers in multiple myeloma
-
2:51
cassiopeia: d-vtd in high-risk multiple myeloma
-
2:01
the evolution of bcl2 inhibition in cll
-
2:21
mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
-
4:15
the role of bone marrow stromal cells in myeloma progression and drug resistance
-
4:53
eha 2024 | descar-t registry
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
0:52
the importance of incorporating frailty assessment tools in clinical practice for multiple myeloma
-
2:01
the key unmet needs in a post-allosct newly diagnosed myeloma setting
-
9:52
myeloma highlights from soho 2023: updates with the use of novel targeted immunotherapies
-
1:03
columba study update: subcutaneous daratumumab in r/r mm
-
0:56
recent updates on narsoplimab for ta-tma
-
2:12
updates from icaria-mm: longer-term efficacy data on the combination of isa-pd in r/r myeloma
-
1:30
vcdi for multiple myeloma: an update
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
1:58
updates: dpd treatment in patients with r/r myeloma